NCT06259578 - UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study) | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

August 29, 2024

Study Completion Date

December 29, 2024

Conditions

COVID-19 PandemicCOVID-19 VaccinesCOVID-19 Virus Disease

Interventions

BIOLOGICAL

INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg

1 dose of 0.5 ml containing inactivated SARS-CoV-2 virus (5 μg ), Tween 80, histidine, Polysorbate 80, Aluminium hydroxide gel, and sodium chloride

Trial Locations (1)

RECRUITING

Dr. Soetomo General Hospital, Surabaya